Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent embolic cerebral infarction and anticoagulation

R L Koller

    Neurology
    |March 1, 1982
    PubMed
    Summary

    Early anticoagulation therapy for embolic cerebral infarction appears safer than the risk of recurrent events. This study suggests prompt treatment may reduce dangerous re-infarctions in stroke patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intravenous thrombolytic therapy for acute ischemic stroke. Weighing the risks and benefits of tissue plasminogen activator.

    Postgraduate medicine·1998
    Same author

    Prevention of recurrent ischemic stroke.

    Postgraduate medicine·1991
    Same author

    Cervical bruits: clinical correlates of stenosis.

    Angiology·1991
    Same author

    Strawberry pickers' palsy.

    Archives of neurology·1980
    Same author

    The present status of tracheotomy in bulbar poliomyelitis.

    Transactions of the ... annual meeting of the American Laryngological Association. American Laryngological Association. Annual Meeting·1952
    Same author

    The present status of tracheotomy in bulbar poliomyelitis.

    The Annals of otology, rhinology, and laryngology·1951

    Area of Science:

    • Neurology
    • Cardiology
    • Vascular Medicine

    Background:

    • Embolic cerebral infarction poses a significant risk of recurrent events.
    • Recurrent embolic infarctions can lead to severe outcomes, including fatality.

    Purpose of the Study:

    • To evaluate the safety and efficacy of early therapeutic anticoagulation in patients with embolic cerebral infarction.
    • To compare the risk of recurrent embolic infarction with the potential risks of early anticoagulation.

    Main Methods:

    • Retrospective review of hospital course for 44 patients diagnosed with embolic cerebral infarction.
    • Analysis of recurrence rates, timing of recurrences, and management strategies including therapeutic anticoagulation.

    Main Results:

    • Eleven patients (25%) experienced recurrent embolic infarction, with three fatalities.
    • Two recurrences occurred within 48 hours, and one occurred 6 days post-initial event.
    • Sixteen embolic infarctions were treated with early anticoagulation (within 48 hours) without adverse effects.

    Conclusions:

    • The risk associated with early anticoagulation appears lower than the risk of experiencing a recurrent embolic infarction.
    • Prompt anticoagulation may be a beneficial management strategy for embolic cerebral infarction to prevent further strokes.

    Related Experiment Videos